UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000019815
Receipt No. R000022896
Scientific Title A retrospective investigating about an amount of mepivacaine after transurethral resection of the bladder tumor for patients with bladder tumor ultrasound guided technique vs landmark technique
Date of disclosure of the study information 2015/11/17
Last modified on 2015/11/30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A retrospective investigating about an amount of mepivacaine after transurethral resection of the bladder tumor for patients with bladder tumor ultrasound guided technique vs landmark technique
Acronym A retrospective investigating about an amount of mepivacaine after transurethral resection of the bladder tumor
Scientific Title A retrospective investigating about an amount of mepivacaine after transurethral resection of the bladder tumor for patients with bladder tumor ultrasound guided technique vs landmark technique
Scientific Title:Acronym A retrospective investigating about an amount of mepivacaine after transurethral resection of the bladder tumor
Region
Japan

Condition
Condition transurethral resection of the bladder tumor
Classification by specialty
Urology Anesthesiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 the efficacy for the ultrasound guided nerve block
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes an amount of mepivacaine
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
99 years-old >=
Gender Male and Female
Key inclusion criteria 1)transurethral resection of the bladder tumor
2)anesthesia is the combination spinal anesthesia and bilateral ONB.
Key exclusion criteria 1)anesthesia is the general anesthesia without spinal anesthesia
2)lateral ONB
3)unfitness cases
Target sample size 60

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Hironobu Ueshima
Organization Showa University Hospital
Division name Anesthesiology
Zip code
Address 1-5-8 Hatanodai, Shinagawa-ku, Tokyo
TEL 03-3784-8575
Email ueshimhi@yahoo.co.jp

Public contact
Name of contact person
1st name
Middle name
Last name Hironobu Ueshima
Organization Showa University Hospital
Division name Anesthesiology
Zip code
Address 1-5-8 Hatanodai, Shinagawa-ku, Tokyo
TEL 03-3784-8575
Homepage URL
Email ueshimhi@yahoo.co.jp

Sponsor
Institute Showa University Hospital
Institute
Department

Funding Source
Organization Showa University Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 11 Month 17 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 11 Month 17 Day
Date of IRB
Anticipated trial start date
2015 Year 11 Month 17 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information patient background between April, 2015 and September, 2015):BMI, ASA class
an amount of mepivacaine(1%)
complications

Management information
Registered date
2015 Year 11 Month 17 Day
Last modified on
2015 Year 11 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022896

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.